Similar to NRP2, NRP1 is expressed on various types of tumor cells and its expression correlates with tumor progression or a poorer prognosis in several cancers such as prostate, breast, non-small-cell lung carcinoma (NSCLC) and glioma [6,40,41]. Here, NRP1 is linked to glioma.